|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Foster Wheeler France Awarded EPCm Contract for EPAX's Fish Oil Facility at Seal Sands, Teesside, UK
7/16/2012 9:59:19 AM
ZUG, Switzerland--(BUSINESS WIRE)--Foster Wheeler AG (Nasdaq: FWLT) announced today that a subsidiary of its Global Engineering and Construction Group has been awarded a contract by EPAX Pharma UK Limited, the UK subsidiary of Trygg Pharma AS, based in Norway, for the provision of engineering, procurement and construction management (EPCm) services to convert parts of the former Lundbeck pharmaceutical plant at Seal Sands, Teesside, UK, to process fish oil to produce an omega-3 active pharmaceutical ingredient.
|
|
|
|
|
|
|
|
|
|
|